论文部分内容阅读
目的:观察蒙脱石散联合连蒲双清片治疗肠炎的临床疗效。方法:选取我院2012年1月至2014年10月临床收治的150例肠炎患者,将其随机分为两组,各75例。观察组采用蒙脱石散联合连蒲双清片治疗,对照组单用蒙脱石散治疗,比较两组治疗有效率,病情反复发生率及症状、体征改善和消失时间。结果:观察组治疗总有效率为92.00%,对照组为77.33%,观察组明显高于对照组(P<0.05);观察组与对照组、病情反复发生率分别为9.33%和28.00%,观察组显著低于对照组,差异有统计学意义(P<0.01);观察组患者症状、体征改善和消失时间均短于对照组,两组比较差异显著(P<0.01)。结论:蒙脱石散联合连蒲双清片治疗肠炎疗效显著,可缩短病程,减少患者痛苦,且病情反复现象少,安全可靠,值得临床推广应用。
Objective: To observe the clinical efficacy of montmorillonite powder combined with Pu Shuangqing tablets in the treatment of enteritis. Methods: A total of 150 patients with enteritis admitted to our hospital from January 2012 to October 2014 were randomly divided into two groups, 75 cases each. The observation group was treated with montmorillonite powder combined with Pu Shuangqing tablets and the control group with montmorillonite powder alone. The treatment efficiency, recurrence rate, symptoms, signs and signs disappeared in both groups were compared. Results: The total effective rate was 92.00% in the observation group and 77.33% in the control group, which was significantly higher in the observation group than in the control group (P <0.05). The recurrence rates of the observation group and the control group were 9.33% and 28.00%, respectively (P <0.01). The symptoms and signs of patients in the observation group were significantly shorter than those in the control group (P <0.01). Conclusion: The combination of montmorillonite powder and Pu Shuang Qing Tablet has significant effect on treating enteritis, which can shorten the course of disease and reduce the pain of the patients. It is safe, reliable and worthy of clinical application.